Researchers in the UK say that AstraZeneca's benralizumab can have a dramatic impact if used to treat acute asthma attacks, calling it the first major advance for this aspect of the disease in 50 ...
AZ is hoping that Fasenra (benralizumab) could join rival drugs from Sanofi/Regeneron and GlaxoSmithKline as approved therapies for chronic rhinosinusitis with nasal polyps (CRSwNP) that have been ...
The GloBodies are bound by benralizumab-specific ADA in plasma/serum and complexes are captured by immobilized protein G and quantitated using luminometry, following the addition of nanoluciferase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback